Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1479372013 | Cutaneous suspension | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3541795016 | Conventional release cutaneous suspension (dose form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3541796015 | Conventional release cutaneous suspension | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4728341000005111 | kutansuspension | da | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | dansk modul |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Cutaneous suspension | Is a | kutan OG/ELLER transdermal doseringsform | false | Inferred relationship | Some | ||
| Cutaneous suspension | Is a | lægemiddelsuspension | false | Inferred relationship | Some | ||
| Cutaneous suspension | Is a | Cutaneous dose form | true | Inferred relationship | Some | ||
| Cutaneous suspension | Has dose form administration method (attribute) | Apply (administration method) | true | Inferred relationship | Some | ||
| Cutaneous suspension | Has dose form intended site (attribute) | Cutaneous (intended site) | true | Inferred relationship | Some | ||
| Cutaneous suspension | Has dose form release characteristic (attribute) | Conventional release (release characteristic) | true | Inferred relationship | Some | ||
| Cutaneous suspension | Has basic dose form (attribute) | Suspension | true | Inferred relationship | Some | ||
| Cutaneous suspension | Has dose form transformation (attribute) | No transformation | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Cutaneous suspension spray | Is a | False | Cutaneous suspension | Inferred relationship | Some | |
| ciclopirox 0,77 % suspension til topikal anvendelse | Has manufactured dose form | False | Cutaneous suspension | Inferred relationship | Some | |
| Calcipotriene 0.005%/betamethasone 0.064% topical suspension | Has manufactured dose form | False | Cutaneous suspension | Inferred relationship | Some |
This concept is not in any reference sets
FHIR